BAROSTIM NEO is reimbursed on the basis of the “reasonable and medical necessity” requirement for Medicare and Commercial patients as outlined by Centers of Medicare and Medicaid. For coverage questions and support please reach out to

BAROSTIM THERAPY Patient Access Support Program

CVRx provides BAROSTIM THERAPY Patient Access Program support to all providers. The program includes prior authorization service, assistance in coding and billing, claim filing and hotline support before and after implant. To sign up for the program, contact us at


For support with coding, billing, coverage or claims, email us at

A New Approach to Heart Failure Treatment

Make a Difference with BAROSTIM THERAPY

Contact Us